Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes

Toxicon

Volumn 34, Issue 9, 1996, Pages 1058-1061

  Couet, C E ^a   Hopley, J ^b   Hanley, A B ^a  

^a CENTRE FOR ENVIRONMENT   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PYRROLIZIDINE ALKALOID; RETRONECINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; METABOLIC ACTIVATION; MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030246934     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-0101(96)00056-6     Document Type: Article

References (17)

1. Adams, R. and Hale, J. B. (1939) The structure of monocrotaline, the alkaloid in Crotalaria spectabilis and Crotalaria retusa. J. Am. chem. Soc. 61, 2815-2819.
2. Chesney, C. F., Allen, J. R. and Hsu, I. C. (1974a) Right ventricular hypertrophy in monocrotaline pyrrole treated rats. Expl molec. Path. 20, 257-268.
3. Chesney, C. F.. Hsu, I. C. and Allen, J. R. (1974b) Modifications of the in vitro metabolism of the hepatotoxic pyrrolizidine alkaloid. monocrotaline. Res. Commun. Chem. Path. Pharmac. 8, 567-570.
4. Covet, C. E., Crews, C. and Hanley, A. B. (1996) Nat. Toxins (in press).
5. Huxtable, R. J. (1990) Activation and pulmonary toxicity of pyrrolizidine alkaloids. Pharmac. Ther. 47, 371.
6. Jago, M. V., Edgar, J. A., Smith, D. W. and Culvenor, C. C. J. (1970) Metabolic conversion of heliotrine based pyrrolizidine alkaloids to dehydroheliotridine. Molec. Pharmac. 6, 402-406.
7. 14C]monocrotaline by isolated perfused rat liver. Drug Metab. Dispos. 19, 516-524.
8. Mattocks, A. R. (1986) Chemistry and Toxicology of Pyrrolizidine Alkaloids. London: Academic Press.
9. Mattocks, A. R. and Legg, R. F. (1980) Antimitotic activity of dehydroretronecine. a pyrrolizidine alkaloid metabolite and some analogous compounds in a rat liver parenchyma cell line. Chem. Biol. Interact. 30, 325-336.
10. Mattocks, A. R. and White, I. N. H. (1971) The conversion of pyrrolizidine alkaloids to dehydroheliotridine derivatives by rat liver in vitro. Chem. Biol. Interact. 3, 383-396.
11. Mattocks, A. R., Jukes, R. and Brown, J. (1989) Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 27, 561-567.
12. Miranda, C. L., Reed, R. L., Guengerich, F. P. and Buhler, D. R. (1991) Role of cytochrome P450 [I]A4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcinogenesis 12, 515-519.
13. Mirsalis, J. C., Steinmetz, K. L., Blazak, W. F. and Spalding, J. W. (1993) Evaluation of the potential of riddelliine to induce unscheduled DNA synthesis, S-phase synthesis or micronuclei following in vivo treatment with multiple doses. Envir. Molec. Mutagen. 21, 265-271.
14. Müller, L., Kasper, P. and Kaufmann, G. (1992) The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism. Mutat. Res. 282, 169-176.
15. O'Keefe, D. P. and Leto, K. J. (1989) Cytochrome P450 from the mesocarp of avocado (Persea americana). Plant Physiol. 89, 1141-1149.
16. Roeder, E. (1995) Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazia 50, 83-98.
17. Shull, L. R.. Buckmaster. G. W. and Cheeke, P. R. (1976) Factors influencing pyrrolizidine (Senecio) alkaloid metabolism: species, liver sulphydryls and rumen fermentation. J. Anim. Sci. 43, 1024-1027.